7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
The DOI matches its Crossref record; 224 of the 225 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, for some individuals, glucose monitoring can provide insight into the impact of lifestyle and medication management on blood glucose and symptoms, particularly when combined with education and support (53).”
In the citing paper
“Technologies such as intermittently scanned or real-time continuous glucose monitoring (CGM) provide more information and may be useful for people with type 2 diabetes, particularly in those treated with insulin (53,56).”
In the citing paper
“Professional CGM, along with professional interpretation, patient education, and therapy adjustments, may help reduce hyper-and/or hypoglycemia, but rigorous data are lacking (105).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [105]
In the citing paper
“Consequently, both guidelines emphasize the concurrent use of 1) HbA1c as a metric upon which therapeutic targets are defined based on randomized controlled trial (RCT) data, 2) continuous glucose monitoring (CGM) to assess effectiveness and safety of treatment among patients at risk for hypoglycemia or to assess overall glycemia when HbA1c is inaccurate, and 3) self-monitoring of blood glucose as”
In the citing paper
“The ADA and KDIGO guidelines highlight the important role of CGM technology in improving diabetes management as a tool to identify and correct glycemic derangements, prevent hypoglycemia, direct medication management, and guide medical nutritional therapy and physical activity, as well as its rapid evolution in affordability and accuracy (2,37) (Supplementary Table 1).”
Citations
Cites
Items 201–224 of 224
FreeStyle Libre: contact irritation versus contact allergy
Aerts, O., Herman, A., Bruze, M., Goossens, A., & Mowitz, M. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32142-6 · Cited by 24
Singh, R., Samuel, C., & Jacob, J. J. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.1.47 · Cited by 24
Katz, L. B., Stewart, L., Guthrie, B., & Cameron, H. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819867396 · Cited by 24
Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis
Kaur, H., Schneider, N., Pyle, L., Campbell, K., Akturk, H. K., & Shah, V. N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0254 · Cited by 24
Asche, C. V., Luo, W., & Aagren, M. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.825590 · Cited by 22
Sai, S., Urata, M., & Ogawa, I. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818821664 · Cited by 20
The frequency of intermittently scanned glucose and diurnal variation of glycemic metrics
Hansen, K. W., & Bibby, B. M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211019382 · Cited by 20
Disposable insulin syringe reuse and aseptic practices in diabetic patients
Thomas, D. R., Fischer, R. G., Nicholas, W. C., Beghe, C., Hatten, K. W., & Thomas, J. N. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02602347 · Cited by 19
Grunberger, G., Rosenfeld, C. R., Bode, B. W., Abbott, S. D., Nikkel, C., Shi, L., & Strange, P. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-019-00173-8 · Cited by 19
Grady, M., Lamps, G., Shemain, A., Cameron, H., & Murray, L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819856665 · Cited by 18 · cited 1×
“are less painful (9) and the ability to reap-”
BackgroundFreckmann, G., Buck, S., Waldenmaier, D., Zschornack, E., Link, M., Jendrike, N., Obstfelder, I., Vetrugno, S., Kamann, S., & Haug, C. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820911105 · Cited by 17
Using digital health technology to prevent and treat diabetes
Kaufman, N., Ferrin, C., & Sugrue, D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2506 · Cited by 17
Seggelke, S. A., Hawkins, R. M., Gibbs, J., Rasouli, N., Wang, C. C. L., & Draznin, B. (2013) · Endocrine Practice · doi:10.4158/ep13404.or · Cited by 16
Insulin pens in elderly diabetic patients
Reinauer, K.-M., Joksch, G., Renn, W., & Eggstein, M. (1990) · Diabetes Care · doi:10.2337/diacare.13.11.1136 · Cited by 15
Charleer, S., Gillard, P., Vandoorne, E., Cammaerts, K., Mathieu, C., & Casteels, K. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13128 · Cited by 14
Eby, E. L., Boye, K. S., & Lage, M. J. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.823091 · Cited by 13
Ribeiro, R. T., Andrade, R., Nascimento do Ó, D., Lopes, A. F., & Raposo, J. F. (2021) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.024 · Cited by 13
Machry, R. V., Cipriani, G. F., Pedroso, H. U., Nunes, R. R., Pires, T. L. S., Ferreira, R., Vescovi, B., de Moura, G. P., & Rodrigues, T. C. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00675-y · Cited by 13
Raval, A. D., Nguyen, M. H., Zhou, S., Grabner, M., Barron, J. O., & Quimbo, R. A. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.10.1111 · Cited by 13
Harrison, B., & Brown, D. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1704253 · Cited by 12
Al Hayek, A., Al Dawish, M., & El Jammal, M. (2021) · Cureus · doi:10.7759/cureus.16007 · Cited by 11
Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1843423 · Cited by 9
Gill, M., Chhabra, H., Shah, M., Zhu, C., & Grunberger, G. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0220 · Cited by 8
Raval, A. D., Nguyen, M. H., Zhou, S., Grabner, M., Barron, J., & Quimbo, R. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.18438 · Cited by 8
Research works printed but not linked: 1
- Chandran, 2015, Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus, Am Health Drug Benefits, 8, 148
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S97-S112
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200316649
- Semantic Scholar
- 485b3c0c22c51827fd245d87ab7936a39cae732b
- Cited by
- 358
- References
- 225
- Citations by year
- 2026: 21 · 2025: 34 · 2024: 49 · 2023: 106 · 2022: 98 · 2021: 27
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes technology, clinical guidelines, treatment goals, quality of care, diabetes management
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.